GlassScriptPhysician profile
Sean P Cronin
NPI 1710407515
$2,023.37
in general payments reported to CMS, 2019-2025
13 companies · $472 in 2025
The $472 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $233 · 2024: $1,318 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,023 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,023.37 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,057.96 | 2024 | |
| Abbvie INC. | $241.11 | 2024-2025 | |
| Caris Mpi, INC. | $153.44 | 2025 | Mi Cancer Seek |
| Kerecis Limited | $146.25 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Tempus Ai, INC | $100.37 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $90.01 | 2023-2024 | Lynparza |
| Glaxosmithkline, LLC. | $50.16 | 2024-2025 | Jemperli, Zejula |
| Aveo Pharmaceuticals, INC. | $40.92 | 2025 | |
| Eisai INC. | $38.88 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.12 | 2025 | Iclusig |
| Janssen Biotech, INC. | $29.00 | 2025 | Tecvayli, Darzalex |
| Genzyme Corporation | $19.44 | 2025 | |
| Merck Sharp & Dohme LLC | $18.71 | 2025 | Lynparza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Cronin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.